Plasma Protein Binding as an Optimizable Parameter for In Vivo Efficacy

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Plasma protein is crucial for understanding pharmacokinetics, pharmacodynamics, and safety, yet it is often not recommended as a primary parameter for optimization in drug design. This study challenges this view by revisiting established pharmacokinetic models to elucidate a bidirectional strategy for clearance-dependent optimization of plasma protein binding. The analysis shows that strategically modulating plasma protein binding can enhance drug efficacy and safety, supporting its consideration as a key factor in the drug design process.

Article activity feed